Artemis Wealth Advisors, LLC Kala Pharmaceuticals, Inc. Transaction History

Artemis Wealth Advisors, LLC

  • $1.07 Billion
  • Q3 2024

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Aug 21, 2023
BUY
$0.61 - $1.84 $7,891 - $23,804
12,937 New
12,937 $17,000
Q1 2022

Apr 22, 2022
BUY
$0.61 - $1.84 $7,891 - $23,804
12,937 New
12,937 $18,000
Q1 2021

Sep 11, 2023
BUY
$6.24 - $9.58 $80,726 - $123,936
12,937 New
12,937 $87,000
Q3 2020

Sep 05, 2023
BUY
$7.5 - $11.11 $52,875 - $78,325
7,050 Added 119.76%
12,937 $97,000
Q3 2020

Feb 17, 2023
BUY
$7.5 - $11.11 $52,875 - $78,325
7,050 Added 119.76%
12,937 $97,000
Q1 2020

Sep 05, 2023
BUY
$3.83 - $8.79 $22,547 - $51,746
5,887 New
5,887 $51,000
Q1 2020

Feb 17, 2023
BUY
$3.83 - $8.79 $22,547 - $51,746
5,887 New
5,887 $52,000
Q1 2019

Sep 01, 2023
BUY
$5.19 - $8.97 $30,553 - $52,806
5,887 New
5,887 $48,000
Q1 2019

Feb 13, 2023
BUY
$5.19 - $8.97 $30,553 - $52,806
5,887 New
5,887 $49,000
Q4 2018

Feb 09, 2023
BUY
$4.29 - $9.94 $25,255 - $58,516
5,887 New
5,887 $29,000
Q2 2018

Aug 29, 2023
BUY
$13.3 - $17.49 $34,792 - $45,753
2,616 Added 79.98%
5,887 $80.8 Million
Q2 2018

Feb 09, 2023
BUY
$13.3 - $17.49 $34,792 - $45,753
2,616 Added 79.98%
5,887 $81,000
Q1 2018

Aug 29, 2023
BUY
$12.26 - $18.98 $40,102 - $62,083
3,271 New
3,271 $51.8 Million
Q1 2018

Feb 09, 2023
BUY
$12.26 - $18.98 $40,102 - $62,083
3,271 New
3,271 $52,000

Others Institutions Holding KALA

# of Institutions
1
Shares Held
1
Call Options Held
0
Put Options Held
0
View Full List

About Kala Pharmaceuticals, Inc.

KALA Quotes by TradingView
  • Ticker KALA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,464,160
  • Market Cap $8.67M
  • Description
  • Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...
More about KALA
Track This Portfolio

Track Artemis Wealth Advisors, LLC Portfolio

Follow Artemis Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artemis Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Artemis Wealth Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email